CAS: 1931994-81-8
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
N-[6-(1-hydroxy-1-methyl-ethyl)-2-(2-methylsulfonylethyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide REF: IN-DA01X9RWCAS: 1931994-81-8 | 98% | A consultar | Ter 10 Dez 24 | |
Zabedosertib REF: TM-T37076CAS: 1931994-81-8 | 98.48% | A consultar | Seg 27 Jan 25 | |
N-[6-(1-Hydroxy-1-methyl-ethyl)-2-(2-methylsulfonylethyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide REF: 3D-GCD99481CAS: 1931994-81-8 | Min. 95% | - - - | Produto descontinuado |
N-[6-(1-hydroxy-1-methyl-ethyl)-2-(2-methylsulfonylethyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CAS:1931994-81-8
Fórmula:
C20H21F3N4O4S
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
470.4653
Ref: IN-DA01X9RW
25mg | 157,00 € | ||
50mg | 197,00 € | ||
100mg | 316,00 € |
Entrega estimada em Estados Unidos, Terça-feira 10 de Dezembro de 2024
Zabedosertib
CAS:1931994-81-8
Zabedosertib (BAY 1834845) is an inhibitor of IRAK4 with immunomodulatory potential.
Fórmula:
C20H21F3N4O4S
Pureza:
98.48%
Cor e Forma:
Liquid
Peso molecular:
470.47
Ref: TM-T37076
1mg | 42,00 € | ||
5mg | 95,00 € | ||
10mg | 132,00 € | ||
25mg | 216,00 € | ||
50mg | 316,00 € | ||
100mg | 442,00 € | ||
500mg | A consultar | ||
1mL*10mM (DMSO) | 95,00 € |
Entrega estimada em Estados Unidos, Segunda-feira 27 de Janeiro de 2025
N-[6-(1-Hydroxy-1-methyl-ethyl)-2-(2-methylsulfonylethyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CAS:1931994-81-8
Please enquire for more information about N-[6-(1-Hydroxy-1-methyl-ethyl)-2-(2-methylsulfonylethyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide including the price, delivery time and more detailed …
Fórmula:
C20H21F3N4O4S
Pureza:
Min. 95%
Peso molecular:
470.5 g/mol
Ref: 3D-GCD99481
1g | Descontinuado | Solicitar informações | |
50mg | Descontinuado | Solicitar informações | |
100mg | Descontinuado | Solicitar informações | |
250mg | Descontinuado | Solicitar informações | |
500mg | Descontinuado | Solicitar informações |